Trevena - Stock Price History | TRVN

Historical daily share price chart and data for Trevena since 2021 adjusted for splits. The latest closing stock price for Trevena as of October 15, 2021 is 1.14.
  • The all-time high Trevena stock closing price was 13.30 on September 18, 2015.
  • The Trevena 52-week high stock price is 3.10, which is 171.9% above the current share price.
  • The Trevena 52-week low stock price is 1.09, which is 4.4% below the current share price.
  • The average Trevena stock price for the last 52 weeks is 1.89.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Trevena Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 1.6301 0.8582 3.2600 0.4750 2.1400 154.49%
2019 1.0678 0.5455 1.8800 0.5098 0.8409 95.56%
2018 1.5086 1.8000 3.4700 0.3888 0.4300 -73.13%
2017 3.1521 6.1500 7.9400 1.4000 1.6000 -72.79%
2016 7.0297 9.7800 9.8800 3.8100 5.8800 -44.00%
2015 7.8418 5.6500 13.3000 4.8300 10.5000 75.59%
2014 5.8707 6.5000 9.6400 3.9800 5.9800 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.188B $0.003B
Trevena, Inc. is a biopharmaceutical company. It focuses on discovering and developing therapeutics for G protein coupled receptors. The Company's product pipeline includes TRV027, TRV130, TRV734 and Delta opioid biased ligand which are in different clinical phases. Trevena, Inc. is based in King of Prussia, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00